Viqus Logo Viqus Logo
Home
Categories
Language Models Generative Imagery Hardware & Chips Business & Funding Ethics & Society Science & Robotics
Resources
AI Glossary Academy CLI Tool Labs
About Contact

OpenAI Bets Big on Brain-Computer Interfaces with Merge Labs

AI Brain Computer Interface OpenAI Sam Altman Merge Labs Fundraising Silicon Valley
January 15, 2026
Viqus Verdict Logo Viqus Verdict Logo 8
Humanity 2.0?
Media Hype 9/10
Real Impact 8/10

Article Summary

OpenAI’s latest investment, a $250 million seed round in Merge Labs, highlights a bold foray into the rapidly developing field of brain-computer interfaces (BCIs). Merge Labs, founded by Sam Altman associate Alex Blania and Sandro Herbig, aims to ‘bridge biological and artificial intelligence’ to ‘maximize human ability,’ focusing on non-invasive technologies like ultrasound to connect with neurons. This investment deepens Altman’s competition with Elon Musk’s Neuralink, while also expanding OpenAI's interests beyond its core language model business. The round includes co-founders like Tyson Aflalo and Sumner Norman, prominent figures within the burgeoning BCI space, alongside researchers from Caltech. Merge Labs’ mission – to create a natural, human-centered AI interaction through BCIs – aligns with OpenAI's longer-term vision of a merged human-AI future, as outlined by Altman himself since at least 2017. This deal underscores OpenAI’s strategic pursuit of cutting-edge technology, potentially accelerating advancements in neurotechnology and establishing a crucial foothold in a sector ripe with both immense potential and significant ethical considerations. The arrangement also reveals a familiar pattern in Altman’s investments, leveraging resources from OpenAI to bolster ventures he personally champions, further increasing the value of his holdings.

Key Points

  • OpenAI has invested $250 million in Merge Labs, a significant commitment to the BCI sector.
  • The investment reflects OpenAI's long-term vision of a ‘merged human-AI future,’ aligning with Sam Altman's own prior speculation.
  • This investment intensifies competition between OpenAI and Neuralink, showcasing a strategic effort to dominate emerging AI technologies.

Why It Matters

This investment isn't simply about funding a startup; it's a statement about OpenAI’s ambitions and where it believes the future of AI lies. BCIs represent a potentially transformative technology with applications ranging from treating neurological disorders to augmenting human capabilities – a scenario that has long been a subject of speculation by Altman and other AI visionaries. For professionals in AI, neuroscience, and venture capital, this news signals a critical inflection point, highlighting the growing influence of Big Tech in a field poised to reshape our understanding of the human mind and its interaction with machines. It also raises fundamental questions about the ethical and societal implications of increasingly sophisticated BCI technology.

You might also be interested in